PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-248

  1. 5,013 Posts.
    lightbulb Created with Sketch. 654
    At what point should shareholders start worrying about the sp? After all we bought into this to make money. Yes bio takes time but we aren’t expecting $20/share next year. We just want to see it moving in the right direction, not backwards. I can see people in a year or 2 saying the same thing ‘fundamentals are good etc etc and I’m not worried about the sp blah blah blah’ or still blaming inflation or the war. Nobody believes PR and his story atm and something needs to change otherwise we will be saying the same thing in 2 years time.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.